The Latest SPAC News and Rumors: October 27, 2021
by Marlena Haddad on 2021-10-27 at 11:55am

Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News: Tim Hortons China hits 300 stores, Science 37 collaborates with 3H Medi Solution to enable decentralized clinical trials in Japan, and DocGo triples third quarter revenues


Tim Hortons China Hits 300 Stores Undeterred by Listing Delay

TH International Ltd., also known as Tims China, a joint venture of Restaurant Brands International Inc. and the private equity firm Cartesian Capital Group, said it has opened its 300th store in the world’s most populous country. The more than two-fold jump — it had 137 outlets at the beginning of 2021 — underscores the coffee chain’s big bet on China despite recurring flare-ups of Covid-19 that has curtailed consumer demand and triggered curbs on movement.

READ

Science 37 and 3H Medi Solution Collaborate to Enable Decentralized Clinical Trials in Japan and Accelerate Patient Enrollment

Science 37, the Operating System for today’s more agile clinical trials and 3H Medi Solution Inc., a clinical trials solution leader in Japan today announced a collaboration to further decentralized clinical trials and accelerate the development of therapies. In this partnership, 3H Medi Solution will use Science 37’s clinical trial Operating System with its end-to-end technology platform for eConsent, electronic data capture, patient management, telemedicine and mobile nurse operations.

On October 7, Science 37, Inc. (NASDAQ:SNCE) completed its business combination with LifeSci Acquisition II Corp.

READ

DocGo Continues on Exponential Growth Track; Triples Third Quarter Revenues, Enters New Markets and Secures Major Partnerships

DocGo, a leading provider of last-mile mobile health services and integrated medical mobility solutions that has entered into an agreement to merge with Motion Acquisition Corp. (NASDAQ:MOTN), continues on its exponential growth trajectory, reporting Q3 revenues of $81 million, a 200% increase over the previous year, and rolling out a series of major initiatives and joint partnerships.

With continued growth on the horizon, the mobile health services company is poised to disrupt the healthcare industry with its combined Mobile Health and medical transportation offering.  DocGo is the current operating trade name for Ambulnz, Inc. Upon consummation of the merger, the combined company will be renamed DocGo, Inc.

READ

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved